Cargando…

YAP: a novel target for Alzheimer's disease

Detalles Bibliográficos
Autores principales:	Xu, Xingxing, Wang, Ying, Huang, Zhihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134940/ https://www.ncbi.nlm.nih.gov/pubmed/35482299 http://dx.doi.org/10.18632/aging.204045

Ejemplares similares

YAP prevents premature senescence of astrocytes and cognitive decline of Alzheimer's disease through regulating CDK6 signaling
por: Xu, Xingxing, et al.
Publicado: (2021)

A Glowing Opportunity to Target YAP in Lung Fibrosis
por: Neubig, Richard R.
Publicado: (2022)

Novel therapeutic target against Alzheimer
por: LeBlanc, Andrea C.
Publicado: (2017)

“Yap”-ing about the Antifibrotic Benefits of Prostacyclin
por: Huang, Steven K.
Publicado: (2019)

YAP as oncotarget in uveal melanoma
por: Yu, Fa-Xing, et al.
Publicado: (2014)

Novel Therapeutics in Alzheimer's Disease
por: Sabbagh, Marwan, et al.
Publicado: (2012)

YAP and TAZ in Lung Development: The Timing Is Important
por: Warburton, David
Publicado: (2020)

D-galactose induces senescence of glioblastoma cells through YAP-CDK6 pathway
por: Xu, Xingxing, et al.
Publicado: (2020)

Astrocytic YAP prevents the demyelination through promoting expression of cholesterol synthesis genes in experimental autoimmune encephalomyelitis
por: Zhang, Jingjing, et al.
Publicado: (2021)

Gatekeepers of pancreas: TEAD and YAP
por: Rodríguez-Seguí, Santiago A., et al.
Publicado: (2015)

YAP Is a Critical Inducer of SOCS3, Preventing Reactive Astrogliosis
por: Huang, Zhihui, et al.
Publicado: (2016)

YAP signaling in horizontal basal cells promotes the regeneration of olfactory epithelium after injury
por: Wu, Qian, et al.
Publicado: (2022)

Alzheimer's Disease and Cognitive Frailty: Novel Therapeutic Technologies
por: D'Onofrio, Grazia, et al.
Publicado: (2016)

Targeting YAP in malignant pleural mesothelioma
por: Zhang, Wen‐Qian, et al.
Publicado: (2017)

BACE1: from biomarker to Alzheimer’s disease therapeutical target
por: Cervellati, Carlo, et al.
Publicado: (2021)

Circular RNA YAP1: a new player in gastric cancer
por: Verduci, Lorena, et al.
Publicado: (2019)

YAP promotes the proliferation of neuroblastoma cells through decreasing the nuclear location of p27(Kip1) mediated by Akt
por: Shen, Xiya, et al.
Publicado: (2019)

Progress in novel cognitive enhancers for cognitive aging and Alzheimer’s disease
por: Shineman, Diana W, et al.
Publicado: (2013)

Editorial of special column on Drug targets and drug development for Alzheimer's disease
por: Ding, Wen-Xing, et al.
Publicado: (2022)

The Telluride YAP/TAZ and TEAD Workshop: A Small Meeting with a Big Impact
por: Weinberg, Guy L., et al.
Publicado: (2023)

Novel Molecular Targets in Malignant Diseases of Digestive System 2014
por: Jiang, Chunping, et al.
Publicado: (2015)

Atypical PKC: therapeutic target for Alzheimer’s?
por: Farese, Robert V., et al.
Publicado: (2018)

Editorial: Targets for Disease-Modifying Therapies in Alzheimer’s Disease, Including Amyloid β and Tau Protein
por: Parums, Dinah V.
Publicado: (2021)

Novel Molecular Targets in Malignant Diseases of Digestive System
por: Jiang, Chunping, et al.
Publicado: (2013)

Astrocytic YAP protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model through TGF-β signaling
por: Wu, Qian, et al.
Publicado: (2021)

Toward the Discovery of a Novel Class of YAP–TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP–TEAD Protein–Protein Interface
por: Gibault, Floriane, et al.
Publicado: (2018)

YAP regulates liver size and function
por: Miyamura, Norio, et al.
Publicado: (2018)

Pathogenesis of Alzheimer’s Disease
por: Rostagno, Agueda A.
Publicado: (2022)

Metals and Alzheimer's Disease
por: White, Anthony R., et al.
Publicado: (2011)

Care for Alzheimer's Disease
por: Umegaki, Hiroyuki, et al.
Publicado: (2013)

Microglia in Alzheimer's Disease
por: Jin, Lee-Way
Publicado: (2012)

ASM in Alzheimer's disease
por: Lee, Jong Kil, et al.
Publicado: (2015)

Aducanumab for Alzheimer’s disease?
por: Walsh, Sebastian, et al.
Publicado: (2021)

Frontier on Alzheimer’s Disease
por: Cervellati, Carlo, et al.
Publicado: (2023)

Novel Targets for Old and Diseased Hearts
por: Rurali, Erica, et al.
Publicado: (2022)

News & views: anti-amyloid antibodies and novel emerging approaches to Alzheimer’s disease in 2023
por: Gandy, Sam
Publicado: (2023)

Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling
por: Xu, Jiayun, et al.
Publicado: (2022)

YAP-dependent necrosis occurs in early stages of Alzheimer’s disease and regulates mouse model pathology
por: Tanaka, Hikari, et al.
Publicado: (2020)

NUAK2 is a critical YAP target in liver cancer
por: Yuan, Wei-Chien, et al.
Publicado: (2018)

The Biology and Therapeutic Potential of the Src-YAP Axis in Non-Small Cell Lung Cancer (NSCLC)
por: Papavassiliou, Kostas A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ucip7f7ji7id9nfbhddg7r1616